Passage Bio announces 2023 annual meeting voting results

Passage BIO, Inc.

Elected three Class III directors: Athena Countouriotis (28.6M for), Saqib Islam (24.2M for), Sandip Kapadia (27.4M for).
Ratified KPMG LLP as independent auditor for FY2023: 37.7M for, 279K against, 44K abstain; no broker non-votes.
Approved amendment to certificate of incorporation for officer exculpation: 30.1M for, 1.5M against, 66.7K abstain, 6.2M broker non-votes.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Passage BIO, Inc. shareholders approved Election of three Class III directors at the 2023-05-25 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-05-25

Exact text from the filing

Election of three Class III directors, identified in the table below, each to serve a three-year term, which will expire at the 2026 Annual Meeting of Stockholders and until such time as their respective successors have been duly elected and qualified or until their earlier resignation or removal: Nominees Shares For Shares Withheld Broker Non-Votes Athena Countouriotis, M.D. 28,649,239 3,089,674 6,239,108 Saqib Islam 24,225,087 7,513,826 6,239,108 Sandip Kapadia 27,401,976 4,336,937 6,239,108

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Passage BIO, Inc. shareholders approved Approval of the amendment and restatement of the Company's amended and restated certificate of incorporation to permit the exculpation of the Company's officers from personal liability for certain breaches of the duty of care at the 2023-05-25 meeting.

Proposal: charter amendment
Outcome: passed
Meeting: 2023-05-25

Exact text from the filing

Approval of the amendment and restatement of the Company’s amended and restated certificate of incorporation to permit the exculpation of the Company’s officers from personal liability for certain breaches of the duty of care : Shares For Shares Against Shares Abstaining Broker Non-Votes 30,135,810 1,536,404 66,699 6,239,108

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Passage BIO, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-05-25 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-05-25

Exact text from the filing

Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023: Shares For Shares Against Shares Abstaining Broker Non-Votes 37,654,833 279,241 43,947 -

View on SEC.gov

Browse all shareholder votes →

Passage BIO, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-065493

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.